Product Recalls in Pennsylvania

Product recalls affecting Pennsylvania — including food, drugs, consumer products, medical devices, and vehicles distributed to Pennsylvania. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,878 recalls have been distributed to Pennsylvania in the last 12 months.

55,602 total recalls
2,878 in last 12 months

Showing 61216140 of 13,473 recalls

DrugDecember 20, 2018· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP Recalled by Lupin Pharmaceuticals Inc. Due to...

The Issue: Presence of Particulate Matter: Product complaints received of grey flecks,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 20, 2018· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2018· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM and HYDROCHLOROTHIAZIDE TABLETS Recalled by Torrent...

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2018· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP Recalled by Lupin Pharmaceuticals Inc. Due to...

The Issue: Presence of Particulate Matter: Product complaints received of grey flecks,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 20, 2018· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM and HYDROCHLOROTHIAZIDE TABLETS Recalled by Torrent...

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2018· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP Recalled by Lupin Pharmaceuticals Inc. Due to...

The Issue: Presence of Particulate Matter: Product complaints received of grey flecks,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 20, 2018· Lupin Pharmaceuticals Inc.

Recalled Item: Ceftriaxone for Injection USP Recalled by Lupin Pharmaceuticals Inc. Due to...

The Issue: Presence of Particulate Matter: Product complaints received of grey flecks,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugDecember 20, 2018· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 20, 2018· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: FDA lab confirmed presence an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 19, 2018· Teva Pharmaceuticals USA

Recalled Item: Olmesartan Medoxomil and Hydrochlorothiazide Tablets Recalled by Teva...

The Issue: Failed dissolution specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2018· Promise Pharmacy, LLC

Recalled Item: Ipamorelin+Sermorelin Recalled by Promise Pharmacy, LLC Due to Lack of...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2018· Promise Pharmacy, LLC

Recalled Item: Acetylcysteine Ophthalmic Solution Recalled by Promise Pharmacy, LLC Due to...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2018· Promise Pharmacy, LLC

Recalled Item: Glycyrrhizic Acid Recalled by Promise Pharmacy, LLC Due to Lack of sterility...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2018· Promise Pharmacy, LLC

Recalled Item: Zinc Sulfate Recalled by Promise Pharmacy, LLC Due to Lack of sterility...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2018· Promise Pharmacy, LLC

Recalled Item: Dexpanthenol Recalled by Promise Pharmacy, LLC Due to Lack of sterility...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2018· Promise Pharmacy, LLC

Recalled Item: Thymosin Beta-4 Recalled by Promise Pharmacy, LLC Due to Lack of sterility...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2018· Promise Pharmacy, LLC

Recalled Item: Vitamin B Complex Recalled by Promise Pharmacy, LLC Due to Lack of sterility...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2018· Promise Pharmacy, LLC

Recalled Item: BPC 157 Recalled by Promise Pharmacy, LLC Due to Lack of sterility assurance.

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2018· Promise Pharmacy, LLC

Recalled Item: Prednisolone and Bromfenac Ophthalmic Solution Recalled by Promise Pharmacy,...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugDecember 17, 2018· Promise Pharmacy, LLC

Recalled Item: Ipamorelin+Modified GRF 1-29 Recalled by Promise Pharmacy, LLC Due to Lack...

The Issue: Lack of sterility assurance.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund